رجوع
نطاق اليوم
KWD 14.20
KWD 15.29
نطاق 52 أسبوعًا
KWD 1.01
KWD 16.41
حجم التداول
5,067,498
متوسط 50 يوم / 200 يوم
KWD 11.98
/
KWD 4.61
الإغلاق السابق
KWD 14.60
تاريخ السعر
الاتجاهات المالية
مقارنة الأقران
مقابل وسيط قطاع Healthcare (626 نظير)
| المقياس | السهم | وسيط القطاع |
|---|---|---|
| P/E | -35.7 | 0.4 |
| P/B | 13.7 | 2.9 |
| ROE % | -33.3 | 3.7 |
| Net Margin % | — | 3.9 |
| Rev Growth 5Y % | — | 10.0 |
| D/E | 0.1 | 0.2 |
السعر المستهدف للمحللين
Hold
KWD 11.600
-19.0%
Low: KWD 5.000
High: KWD 20.000
ربحية السهم المستقبلية
-KWD 0.434
الإيرادات المقدّرة
7.5 M
تقديرات الأرباح
| الفترة | تقدير ربحية السهم | تقدير الإيرادات | المحللون |
|---|---|---|---|
| FY2030 |
-KWD 0.396
-KWD 0.396 – -KWD 0.396
|
300 M | 2 |
| FY2029 |
-KWD 0.766
-KWD 0.766 – -KWD 0.766
|
35 M | 4 |
| FY2028 |
-KWD 0.656
-KWD 0.913 – -KWD 0.502
|
3.7 M | 6 |
النقاط الرئيسية
Debt/Equity of 0.14 — conservative balance sheet
Negative free cash flow of -95.58M
PEG of 0.23 suggests growth is underpriced
النمو
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
الجودة
Return on Equity
-33.27%
ROIC-26.47%
Net MarginN/A
Op. MarginN/A
الأمان
Debt / Equity
0.14
Current Ratio10.04
Interest Coverage0.00
التقييم
P/E Ratio
-35.73
P/B Ratio13.69
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 0.0 | Net Income (TTM) | -124.55M |
| ROE | -33.27% | ROA | -31.44% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -95.58M |
| ROIC | -26.47% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 0.14 | Current Ratio | 10.04 |
| Interest Coverage | 0.00 | Dividend Yield | 0.00% |
| Valuation | |||
| P/E Ratio | -35.73 | P/B Ratio | 13.69 |
| P/S Ratio | N/A | PEG Ratio | 0.23 |
| EV/EBITDA | N/A | Dividend Yield | 0.00% |
| Market Cap | 4.45B | Enterprise Value | 4.42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | -124.55M | -161.65M | -125.04M | -242.81M | -122.76M |
| EPS (Diluted) | -0.44 | -0.69 | -0.83 | -1.99 | -1.03 |
| Gross Profit | -3.11M | 0.0 | -3.73M | -2.64M | -829,000.0 |
| Operating Income | -131.41M | -179.59M | -141.53M | -247.45M | -124.88M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 396.15M | 502.53M | 395.30M | 514.91M | 501.42M |
| Total Liabilities | 70.98M | 79.03M | 78.61M | 103.06M | 44.89M |
| Shareholders' Equity | 325.17M | 423.50M | 316.69M | 411.85M | 456.53M |
| Total Debt | 47.14M | 51.89M | 55.86M | 55.10M | 18.79M |
| Cash & Equivalents | 73.81M | 67.74M | 93.08M | 284.22M | 360.49M |
| Current Assets | 286.24M | 308.79M | 320.68M | 444.50M | 420.02M |
| Current Liabilities | 28.51M | 31.40M | 26.16M | 48.69M | 26.22M |